Up to now, 96 different EGLN1 genetic variants have been reported in patients with erythrocytosis, from whom 36 were classified as pathogenic or likely pathogenic, and in almost all cases, patients were heterozygous (22). This evidence concerns the gene EGLN1 and polycythemia.